The Annual General Meeting will be held on 27 May 2021.

Shareholders who wish to have a matter brought before the Annual General Meeting must submit a written request to the Board of Directors. The request must be received by the Board of Directors no later than 8 April 2021. Shareholders may submit their requests by e-mail to styrelse@oasmia.com or by ordinary mail to the following address:

Oasmia Pharmaceutical AB
Att: The Board of Directors
Vallongatan 1
SE 752 28 Uppsala
Sweden